BUY Endurance Technologies Limited — Mehul Kothari, Anand Rathi
byMehul Kothari, Anand RathiHorizon: BTST30 Sept 2026, 2:28 pm ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Endurance Technologies to acquire remaining 32% stake in German Stöferle companies for €18 million
NewsCnbc-Tv18·29 Sept · today
Endurance Technologies Ltd acquired the remaining 32% stake in Stoeferle GmbH and Stoeferle Automotive GmbH through its Italian subsidiary.
BSE · Company Update·29 Sept · today
Market Trading Guide: Quality Power among 3 stock recommendations for Tuesday
NewsEt-Markets·28 Sept · yesterday
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Endurance Technologies
- BUY — Axis Securities5 Nov 2026 · ~1 year · target ₹2,900 · Active
- BUY — Citigroup4 Nov 2026 · ~1 year · target ₹3,550 · Active
- BUY — Ambareesh Baliga21 Oct 2026 · ~2 weeks · target ₹2,940 · Expired
- BUY — Citigroup8 Oct 2026 · ~1 year · target ₹3,350 · Active
- BUY — Prakash Gaba30 Sept 2026 · ~2 weeks · target ₹2,775 · SL hit
More from Mehul Kothari, Anand Rathi
- BUY GMM Pfaudler11 Nov 2026 · ~2 weeks · target ₹1,300 · Active
- BUY Indian Railway Catering And Tourism Corporation11 Nov 2026 · ~2 weeks · target ₹525 · Active
- BUY Canara Bank9 Nov 2026 · ~2 weeks · target ₹155 · Active
- BUY Union Bank of India9 Nov 2026 · ~2 weeks · target ₹202 · Target hit
- BUY Mankind Pharma9 Nov 2026 · ~2 weeks · target ₹3,000 · Active

